Drug	Gene	Type	Source
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	COMT	Text_Mining(decreases(abundance))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	COMT	Text_Mining(decreases(activity))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	COMT	Text_Mining(increases(abundance))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	SNCA	Text_Mining(affects(binding))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	SNCA	Text_Mining(decreases(reaction))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	UGT1A1	Text_Mining(increases(glucuronidation))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	UGT1A10	Text_Mining(increases(glucuronidation))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	UGT1A3	Text_Mining(increases(glucuronidation))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	UGT1A7	Text_Mining(increases(glucuronidation))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	UGT1A8	Text_Mining(increases(glucuronidation))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	UGT1A9	Text_Mining(decreases(glucuronidation))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	UGT1A9	Text_Mining(increases(glucuronidation))	CTD
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	HSPB1	Ratio Potency (uM)=26.6011(uM)	D4 PubChem
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	NFE2L2	Ratio Potency (uM)=16.1523(uM)	D4 PubChem
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-	POLK	Potency=6.7016(uM)	D4 PubChem